Home > PJ (current issue) > News / Daily News | Search

Return to PJ Online Home Page

The Pharmaceutical Journal
Vol 271 No 7261 p166
9 August 2003

This article
Reprint
Photocopy


News summary

Related websites
MLX 294 The sale, supply and administration of medicines by allied health professionals under patient group directions (Microsoft Word document)

Medicines and Healthcare products Regulatory Agency (www.mhra.gov.uk)


Plans to widen PGDs to more health professions

Proposals to allow dietitians, occupational therapists, prosthetists, orthotists and speech and language therapists sell, supply and administer medicines under patient group directions have been put forward in MLX294 by the Medicines and Healthcare products Regulatory Agency.

If accepted, these professions will be added to the list of professionals who are able to operate as named individuals under PGDs. The professions currently in that list are pharmacists, nurses, midwives, health visitors, optometrists, chiropodists/podiatrists, radiographers, orthoptists, physiotherapists and paramedics.

Anne Whateley, deputy chief executive of the Royal College of Speech and Language therapists, said that examples of medicines that speech therapists might need to use included topical anaesthetics following laryngoendoscopy or surgical voice restoration, antifungals and other medicines to relieve mouth ulcers or oral discomfort.

Prosthetists and orthotists might want to use botulinum toxin to treat unresponsive hyperhydrosis of the axillae, baclofen for cerebral palsy or flucloxacillin for soft tissue infections.

Arts therapists have been excluded from the proposal because their professional bodies have concluded that arts therapists have no need to be able to work with PGDs in their current professional practice.

PGDs can be used by the National Health Service, by charitable and voluntary health care organisations and in the armed force, prison and police health services.

Comments on the proposal can be sent to Anne Ryan, MHRA, 16-142 Market Towers, 1 Nine Elms Lane, London SW8 5NG (e-mail anne-ryan@mhra.gsi.gov.uk) until 30 September. The consultation period is less than the usual 12 weeks because there has already been extensive informal consultation with the allied health professions’ representatives.

Back to Top


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal